Oncoteq AG
Biotechnologieforschung
Zug, ZG 279 Follower:innen
Leveraging AI to unleash the full potential of molecules in oncology
Info
Oncoteq AG is a biotechnology company that in-licenses and develops drug molecules for oncology indications - enabled by artificial intelligence (AI) as part of Cureteq AG group First asset is an MetAP2 inhibitor, licensed from Merck KGaA, currently in phase 1 clinical development for oncology indications.
- Website
-
www.cureteq.com
Externer Link zu Oncoteq AG
- Branche
- Biotechnologieforschung
- Größe
- 2–10 Beschäftigte
- Hauptsitz
- Zug, ZG
- Gegründet
- 2022
- Spezialgebiete
- Oncology, Drug Development, Artificial Intelligence, Biotechnology und Clinical Trials